Immediate Impact
4 standout
Citing Papers
Efficacy and safety of bimekizumab in patients with moderate-to-severe hidradenitis suppurativa (BE HEARD I and BE HEARD II): two 48-week, randomised, double-blind, placebo-controlled, multicentre phase 3 trials
2024 Standout
Optimizing the safety of antibody–drug conjugates for patients with solid tumours
2023 Standout
Works of Lenie Denteneer being referenced
Benefits and Disadvantages of Electronic Patient-reported Outcome Measures: Systematic Review
2020
Author Peers
| Author | Last Decade | Papers | Cites | ||||
|---|---|---|---|---|---|---|---|
| Lenie Denteneer | 102 | 49 | 46 | 50 | 11 | 266 | |
| Elena Tseli | 154 | 46 | 32 | 28 | 12 | 320 | |
| Ariana Vora | 42 | 54 | 24 | 84 | 11 | 328 | |
| Takayuki Sawada | 173 | 43 | 69 | 14 | 12 | 295 | |
| Sophie Alami | 98 | 96 | 59 | 27 | 17 | 332 | |
| Norimasa Kikuchi | 164 | 44 | 68 | 15 | 11 | 331 | |
| Nolwenn Poquet | 164 | 47 | 30 | 31 | 8 | 300 | |
| Jhb Geertzen | 152 | 40 | 54 | 21 | 8 | 313 | |
| Ian M. Fowler | 140 | 88 | 67 | 27 | 9 | 292 | |
| Gerlienke E. Voerman | 117 | 25 | 23 | 46 | 12 | 331 | |
| Sandrine Plouvier | 181 | 25 | 48 | 14 | 21 | 305 |
All Works
Login with ORCID to disown or claim papers
Loading papers...